ACE-031 (ramatercept) is a recombinant soluble Activin Receptor Type IIB–Fc fusion protein studied as a high-affinity decoy receptor binding myostatin (GDF-8) and related TGF-β superfamily negative regulators of muscle growth.
Scientific Profile & Research Key Points: ACE-031
ACE-031 (ramatercept) is a recombinant soluble Activin Receptor Type IIB–Fc fusion protein studied as a high-affinity decoy receptor binding myostatin (GDF-8) and related TGF-β superfamily negative regulators of muscle growth.
Active Batch Release Specifications (Lot SL-2026-102)
Analytical release verification for current ACE-031 (1 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-102 | 2026-10-28 | SEC-HPLC + SDS-PAGE (Reducing & Non-Reducing) | ≥99.0% (Monomeric Purity) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); avoid mechanical agitation
Temperature & Stability
Store lyophilized fusion protein at -20°C to -80°C. Store reconstituted aliquots at 2°C–8°C for up to 14 days without freeze-thaw cycling.
ACE-031 — Technical Questions & Answers
Why is ACE-031 analyzed by SEC-HPLC and SDS-PAGE instead of standard small-peptide RP-HPLC alone?
At ~79.0 kDa (homodimer), recombinant proteins like ACE-031 possess tertiary and quaternary folding structures that denature under harsh reversed-phase organic gradients. Size-exclusion chromatography (SEC-HPLC) and SDS-PAGE verify monomeric integrity and detect dimers or aggregates.
How do researchers minimize adsorption and aggregation when preparing ACE-031 (1 mg)?
Avoid vigorous vortexing, foaming, or repeated freeze-thaw cycles. Slowly introduce buffer along the borosilicate vial wall and consider low-protein-binding polypropylene tubes (or carrier protein buffer where assay-compatible) for nanomolar working dilutions.
What biological receptor system is ACE-031 used to probe in vitro?
ACE-031 (CAS 1169766-01-1) targets Myostatin (GDF-8), GDF-11, and Activin A ligands (Lyophilized phosphate-buffered formulation). Reference publication: Cadena S.M. et al., J Appl Physiol (2010) — Soluble ActRIIB-Fc ligand trapping in skeletal muscle biology (PMID: 20558758).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
CJC-1295, Ipamorelin, and Sermorelin: GHRH Analogues vs Ghrelin Receptor Agonists
A deep dive into somatotropic axis stimulation. Comparing GHRH receptor binding, DAC modification kinetics, ghrelin/GHS-R1a agonism, and pulsatile growth hormone secretion.
Gonadorelin, HCG, HMG and Kisspeptin: Mapping the Hypothalamic-Pituitary-Gonadal Axis
A comparative map of the HPG axis: GnRH receptor agonism (Gonadorelin), LH receptor mimetics (HCG), combined FSH/LH activity (HMG), and upstream GPR54 activation (Kisspeptin-10).
Human Growth Hormone (191aa): Somatropin Structure, Isoforms, and SEC-HPLC Analysis
A deep analysis of authentic 191-amino acid Somatropin vs 192-amino acid Somatrem. Size-exclusion chromatography (SEC), deamidation artifacts, and mass confirmation.
Related GH Secretagogues & Growth Factors Compounds
View category →